Haemangioma and lymphangioma, any site

DOID EFO MESH SNOMED PheWeb

CD2_BENIGN_HEAMANGIOMA_LYMPHANGIOMA

vulvar carcinoma: A carcinoma that arises from epithelial cells of the mammalian vulva

Endpoint definition

↥

FinnGen phenotype data

392423 individuals

diagram downward connector

Apply sex-specific rule None

392423

diagram downward connector

Check conditions None

392423

diagram downward connector

Check pre-conditions, main-only, mode, registry filters

Hospital Discharge: ICD-10 D18

Cause of death: ICD-10 D18

2 out of 7 registries used, show all original rules.

2260

diagram downward connector

Check minimum number of events None

2260

diagram downward connector

diagram downward connector

Include endpoints

CD2_BENIGN_HEMANGIOMA

CD2_BENIGN_LYMPHANGIOMA

2578

diagram downward connector

diagram downward connector

Remove individuals based on genotype QC

2488

diagram downward connector

CD2_BENIGN_HEAMANGIOMA_LYMPHANGIOMA

Control definitions

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy 2

First used in FinnGen datafreeze DF2

Parent code in ICD-10 D10-D36

Name in latin Haemangioma sive lymphangioma, quovis loco

NAME	CD2_BENIGN_HEAMANGIOMA_LYMPHANGIOMA
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	CD2_BENIGN_HEMANGIOMA\|CD2_BENIGN_LYMPHANGIOMA
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	D18
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	D18
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Show upset plot detailing case counts by codes

Or the full data table

Similar endpoints

↥

List of similar endpoints to Haemangioma and lymphangioma, any site based on the number of shared cases.

Broader endpoints:

Narrower endpoints:

Show all endpoint correlations

Summary Statistics

↥

Key figures

	All	Female	Male
Number of individuals	2488	1592	896
Unadjusted prevalence (%)	0.66	0.76	0.54
Mean age at first event (years)	47.22	45.22	50.77

Mortality

Follow-up	Absolute risk	HR [95% CI]	p	N
1998–2019	0.02	1.49 [0.93, 2.37]	9.4e-2	159
15 years	0.01	0.95 [0.59, 1.51]	8.2e-1	76
5 years	0.00	1.67 [1.03, 2.69]	3.7e-2	39
1 year	0.00	4.54 [2.59, 7.96]	1.4e-7	19

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: CD2_BENIGN_HEAMANGIOMA_LYMPHANGIOMA – Haemangioma and lymphangioma, any site
GWS hits: 1

Survival analyses between endpoints

↥

Plot

before Haemangioma and lymphangioma, any site
after Haemangioma and lymphangioma, any site

Loading survival analyses plot

Table

Loading survival analyses table

Drugs most likely to be purchased after Haemangioma and lymphangioma, any site

↥

Endpoint not on priority list, no data to show.